Startup Spokane and GSI to host SEngine Precision Medicine Elev8Bio - Jan 24

Wednesday, January 24, 2018

Join Startup Spokane and Greater Spokane Incorporated on January 24th from 2:30-4:30 as we welcome Elev8Bio and SEngine Precision Medicine to the Spokane Ecosystem. Cecilia Zapata-Harms, Chief Visionary Officer, will discuss how Elev8Bio marries expertise from across several fields to create a novel platform that assists small and mid-cap companies attempting to break into the fast-paced biotech/life science sector. 

Elev8Bio has knowledge leaders in drug discovery, clinical diagnostics, and clinical trials-to-FDA approval processes. The strategy and marketing leadership and experts at Elev8Bio similarly have deep connections to community, government and academic physician groups. As "Life Science Business Architects", Elev8Bio provides the infrastructure to take life science industries to the next level.

Also, Dr. Carla Grandopri, CEO of SEngine Precision Medicine will share the latest advances in cancer research and personalized treatment in the fight against cancer. With a focus on functional screening, genomics, robotics, cancer organoid cultures, and bioinformatics, SEngine Precision Medicine is providing invaluable data to oncologists and realizing the promise of precise, less toxic and more effective therapies to cancer patients.